The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

GBK Hedestam, Ron Fouchier, S Phogat, DR Burton, J Sodroski, RT Wyatt

Research output: Contribution to journalArticleAcademicpeer-review

260 Citations (Scopus)


The ability to elicit broadly neutralizing antibody responses against HIV-1 is a crucial goal for a prophylactic HIV-1 vaccine. Here, we discuss the difficulties of achieving broad HIV-1 neutralization in the context of both the effective annual human influenza virus vaccine and the need to develop a pandemic influenza vaccine. Immunogen-design strategies are underway to target functionally conserved regions of the HIV-1 envelope glycoproteins, and similar strategies might be applicable to pandemic influenza virus vaccine development. Efforts to develop broadly neutralizing vaccines against either HIV-1 or influenza virus might establish a paradigm for future vaccines against highly variable pathogens.
Original languageUndefined/Unknown
Pages (from-to)143-155
Number of pages13
JournalNature Reviews Microbiology
Issue number2
Publication statusPublished - 2008

Cite this